Literature DB >> 894345

Significance of vasospasm in the treatment of ruptured intracranial aneurysms.

I Saito, Y Ueda, K Sano.   

Abstract

The authors have analyzed a total of 96 consecutive cases in which vasospasm followed subarachnoid hemorrhage (SAH). The SAH was caused by ruptured intracranial aneurysm or developed after aneurysm surgery. Usually at least 4 days elapsed between SAH and the onset of vasospasm. Vasospasm subsided an average of 2 weeks after onset. Of 68 patients with preoperative vasospasm, eight died due to cerebral edema resulting from ischemia, and 49% of survivors had neurological deficits. Preoperative vasospasm was not aggravated by surgical intervention when operations were carried out more than 7 days after the onset of vasospasm. Postoperative vasospasm was found in 25 of 52 patients who underwent operation within 1 week after SAH (excluding cases in Grade V). Five of these patients died, all of whom underwent surgery between the fourth and seventh day after SAH (the day of SAH was counted as the first day). There were no deaths among 20 patients operated on within the first 3 days after SAH. Postoperative vasospasm was always mild in these cases, when it occurred, probably because blood clot or blood-stained cerebrospinal fluid was removed by operative procedures. In all cases, 4 to 11 days elapsed between the last SAH and the onset of postoperative vasospasm regardless of the timing of surgery.

Entities:  

Mesh:

Year:  1977        PMID: 894345     DOI: 10.3171/jns.1977.47.3.0412

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  37 in total

1.  Symptomatic cerebral vasospasm of unusually late onset after aneurysm rupture.

Authors:  K Ohno; H Masaoka; R Suzuki; S Monma; Y Matsushima
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  [Arachidonic acid metabolism following aneurysm rupture].

Authors:  V Seifert; D Stolke; V Kaever; H Dietz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

3.  Ultrastructural changes of the basilar artery following experimental subarachnoid haemorrhage. A morphological study on the pathogenesis of delayed cerebral vasospasm.

Authors:  V Seifert; D Stolke; E Reale
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Alterations of monoamine metabolites and of tryptophan in the basal cisternal CSF of patients after subarachnoid haemorrhage.

Authors:  Y Suzuki; K Ogura; M Shibuya; T Okada; N Kageyama; I Yamamoto; M Hara
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

5.  Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin.

Authors:  E Nishiye; K Nakao; T Itoh; H Kuriyama
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

6.  An experimental study of acute subarachnoid haemorrhage in baboons: changes in cerebral blood volume, blood flow, electrical activity and water content.

Authors:  H Kuyama; A Ladds; N M Branston; M Nitta; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-04       Impact factor: 10.154

7.  Efficacy of steroid hormone in solution for intracranial irrigation during aneurysmal surgery for prevention of the vasospasm syndrome.

Authors:  S Suzuki; K Ogane; M Souma; H Ohkuma; T Iwabuchi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

Authors:  H Fodstad; I M Nilsson
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

9.  The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms.

Authors:  S Sakaki; S Ohta; H Kuwabara; M Shiraishi
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

10.  Effect of continuous cisternal drainage on cerebral vasospasm.

Authors:  T Inagawa; K Kamiya; Y Matsuda
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.